PrCIMZIA® (certolizumab pegol) in combination with methotreaxate (MTX) is indicated for:
PrCIMZIA® may be used alone for reducing signs and symptoms in adult patients with moderately to severely active
rheumatoid arthritis (RA) who do not tolerate MTX.
PrCIMZIA® alone or in combination with methotrexate (MTX) is indicated for:
PrCIMZIA® is indicated for: